IDIV
Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 [IDIV] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
IDIV Stock Summary
In the News
IDIV's Underperformance Explained
IDIV is an S&P 500 dividend futures ETF. S&P 500 dividends have soared, while IDIV's share price plummets.
IDIV ETF: Should Have Stuck With My Original Sell Opinion
The Metaurus US Equity Cumulative Dividends Fund-Series 2027 ETF is a unique exchange-traded fund designed to capture the S&P dividends without the equity risk related to owning those stocks. This article updates my previous reviews, but readers are encouraged to read the prior articles: links provided. I admit I still don't understand some details, but the results speak loudly.
3 Safest Dividend-Paying ETFs to Buy Now
Here are the 3 safest dividend-paying ETFs for getting high income in a turbulent stock market period amid rising interest rates. The post 3 Safest Dividend-Paying ETFs to Buy Now appeared first on InvestorPlace.
IDIV: Dividend Futures ETF, No Compelling Investment Thesis, Sell
A reader and subscriber asked for my thoughts on IDIV. IDIV is a dividend futures ETF, whose returns are strongly dependent on S&P 500 dividend growth rates.
IDIV: Taking A Second Look At This Unique Dividend ETF
Earlier this year, I gave IDIV a Bearish rating based on my initial understanding of how it works and some features that might not appeal to all investors.
The Reopening Killed The V-Shaped Recovery
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
IDIV Financial details
IDIV Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Revenue per share | 0 | 0 | |
| Net income per share | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | |
| Free cash flow per share | 0 | 0 | |
| Cash per share | 0 | 0 | |
| Book value per share | 0 | 0 | |
| Tangible book value per share | 0 | 0 | |
| Share holders equity per share | 0 | 0 | |
| Interest debt per share | 0 | 0 | |
| Market cap | 0 | 0 | |
| Enterprise value | -674.69K | -674.69K | |
| P/E ratio | 0 | 0 | |
| Price to sales ratio | 0 | 0 | |
| POCF ratio | 0 | 0 | |
| PFCF ratio | 0 | 0 | |
| P/B Ratio | 0 | 0 | |
| PTB ratio | 0 | 0 | |
| EV to sales | 0 | 0 | |
| Enterprise value over EBITDA | 40.95 | 6.03 | |
| EV to operating cash flow | -0.02 | 0.06 | |
| EV to free cash flow | -0.02 | 0.06 | |
| Earnings yield | 0 | 0 | |
| Free cash flow yield | 0 | 0 | |
| Debt to equity | 0 | 0 | |
| Debt to assets | 0 | 0 | |
| Net debt to EBITDA | 40.95 | 6.03 | |
| Current ratio | 0 | 0 | |
| Interest coverage | 0 | 0 | |
| Income quality | 0 | 0 | |
| Dividend Yield | 0 | 0 | |
| Payout ratio | 0 | -33.44 | |
| Sales general and administrative to revenue | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | |
| Capex to revenue | 0 | 0 | |
| Capex to depreciation | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | |
| Graham number | 0 | 0 | |
| ROIC | 0 | 0 | |
| Return on tangible assets | 0 | 0 | |
| Graham Net | 0 | 0 | |
| Working capital | 33.76M | 674.69K | |
| Tangible asset value | 33.76M | 34.24M | |
| Net current asset value | 33.28M | 674.69K | |
| Invested capital | 0 | 0 | |
| Average receivables | 0 | 31.95K | |
| Average payables | 0 | 0 | |
| Average inventory | 0 | 0 | |
| Days sales outstanding | 0 | 0 | |
| Days payables outstanding | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | |
| Receivables turnover | 0 | 0 | |
| Payables turnover | 0 | 0 | |
| Inventory turnover | 0 | 0 | |
| ROE | 0 | 0 | |
| Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | -674.69K | -643.65K | -716.59K | -900.03K | -674.69K | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 40.95 | 0 | -0.43 | -0.35 | 0 | |
| EV to operating cash flow | -0.02 | 0 | 0.44 | 0.8 | 0 | |
| EV to free cash flow | -0.02 | 0 | 0.44 | 0.8 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 40.95 | 0 | -0.43 | -0.35 | 0 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 229.14K | |
| Income quality | 0 | 48.32 | 182.04 | 0 | 48.31 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | -802.81 | 0 | 0 | 779.17 | |
| Return on tangible assets | 0 | -771.69 | 0 | 0 | 748.46 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 33.76M | 32.7M | 31.13M | 29.94M | 674.69K | |
| Tangible asset value | 33.76M | 32.6M | 31.28M | 29.25M | 34.24M | |
| Net current asset value | 33.28M | 32.09M | 30.33M | 28.95M | 674.69K | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 152.52K | 153.66K | 151.12K | 118.02K | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | -786.16 | 0 | 0 | 759.15 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
IDIV Frequently Asked Questions
What is Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 stock symbol ?
Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 is a US stock and trading under the symbol IDIV
What is Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 stock quote today ?
Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 stock price is $6.96 today.
Is Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 stock public?
Yes, Metaurus U.S. Equity Cumulative Dividends Fund-Series 2027 is a publicly traded company.
Company Profile
- Volume Average 17.24K
- CEO None
- Headquarters US
- IPO Date 2018-02-05
The advisor intends primarily to invest its assets in the component instruments of the underlying index. The component instruments of the index consist of U.S. Treasury Securities and long positions in annual futures contracts listed on the CME that provide exposure to dividends paid on the S&P 500 constituent companies pro rata for each year of the life of the fund.
